Neurotech International Ltd. (AU:NTI) has released an update. Don't Miss our Black Friday Offers: Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments ...

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, host Sarah Hughan tells all on Neurotech’s (ASX:NTI) vital approval to start its human ...

Neurotech International Ltd. (AU:NTI) has released an update. Don't Miss our Black Friday Offers: Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments ...

To qualify for Breakthrough Device Designation from the US Food and Drug Administration (FDA), a device technology must address an unmet need and provide evidence that it has the potential to provide ...

Neurotech International Ltd. has received ethics approval to begin a pharmacokinetic study of its NTI164 drug in healthy adults, an important step for regulatory compliance in both the U.S. and ...

Enjoy exclusive member discounts, giveaways and competitions with our subscriber rewards program.

The designation is a result of UNEEG’s strong focus on developing novel disease management support tools with transformational and first-to-market potential To qualify for Breakthrough Device ...

Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the new human pharmacokinetic study from Neurotech. In this episode, host Sarah Hughan tells all on Neurotech's (ASX ...